Company profile: Nanostim
1.1 - Company Overview
Company description
- Provider of early-stage medical device technology aimed at preventing complications related to pacemakers, addressing more than 100,000 annual incidents. The company has assembled a world-class team of experienced medical device engineers to bring this technology to market.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nanostim
Renovacor
HQ: United States
Website
- Description: Provider of preclinical-stage biopharmaceutical development of transformative gene therapy-based treatments for cardiovascular disease, featuring a lead recombinant adeno-associated virus (AAV) gene therapy program for patients with dilated cardiomyopathy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Renovacor company profile →
EPD Solutions
HQ: Spain
Website
- Description: Provider of cardiac imaging and navigation systems, dedicated to improving the efficacy and efficiency of minimally invasive catheter-based procedures to treat cardiac arrhythmias; a Dutch company and member of the Hobart Group companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EPD Solutions company profile →
Vascular Insights
HQ: United States
Website
- Description: Provider of medical devices for the minimally invasive treatment of peripheral vascular disease; engages in the design, development, manufacture and marketing of such devices and is the legal manufacturer of ClariVein®, a specialty infusion catheter with a rotating tip for controlled 360-degree dispersion of agents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vascular Insights company profile →
Miracor Medical
HQ: Belgium
Website
- Description: Provider of pressure-controlled intermittent coronary sinus occlusion (PiCSO) therapy and impulse system to treat severe heart diseases, developed and commercialized for cardiac surgeons to facilitate PiCSO treatment in myocardial infarction/heart attack patients undergoing coronary artery bypass grafting, and used during percutaneous coronary intervention (PCI) to reduce infarct size in acute myocardial infarction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Miracor Medical company profile →
CardioMech
HQ: Norway
Website
- Description: Provider of transcatheter devices for structural heart disease, offering an alternative to cardiac surgery for mitral valve chordal repair. Its catheter-based therapy places artificial chords to reduce or eliminate mitral regurgitation without open-heart surgery, giving surgeons new therapeutic options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardioMech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nanostim
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nanostim
2.2 - Growth funds investing in similar companies to Nanostim
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nanostim
4.2 - Public trading comparable groups for Nanostim
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →